1 , 63 (51%) selected comfort care, and 2 (
2%)
were uncertain.
2 are, 37 (30%) chose comfort care, and 8 (
7%)
were uncertain (P<0.001).
3 s optimal to store more fat when food
access is uncertain, and we review the experimental literature
4 However, the diagnostic
accuracy is uncertain with regard to different classes of assays,
5 but to what extent these aims are
achievable is uncertain.
6 optimal dosing interval for zoledronic
acid is uncertain.
7 this association is independent of
adiposity is uncertain.The purpose of this study was to examine th
8 ders (TD/CTD) with autoimmune diseases (
ADs)
is uncertain.
9 acute respiratory illnesses (ARIs) in
adults are uncertain.
10 ascular disease (CVD) events in older
adults is uncertain.
11 alth and the risk of frailty in older
adults is uncertain.
12 adults is dissimilar to that in white
adults is uncertain.
13 lbirth, but its burden in sub-Saharan
Africa is uncertain.
14 n plus either one or two antiplatelet
agents are uncertain.
15 arly life, but their relevance at older
ages is uncertain.
16 of feral cattle on Chirikof Island,
Alaska,
are uncertain.
17 years, when development arrests in
albinism is uncertain.
18 e, if any, in the future treatment
algorithm is uncertain, given the availability of ruxolitinib and
19 ans' sense of equipoise varied: although
all were uncertain about which trial treatment was optimal,
20 childhood acute lymphoblastic leukemia (
ALL)
is uncertain.
21 ns that can be attributed to menopause
alone is uncertain.
22 bonucleotides to chromosome instability
also was uncertain.
23 ugh the nature of their last common
ancestor is uncertain.
24 he future of the primary component,
anchovy,
is uncertain in the context of global warming.
25 after recovery from immune aplastic
anemia,
is uncertain.
26 ance for creation of cumulative
antibiograms is uncertain.
27 ruled out earlier, but the optimal
approach is uncertain.
28 The mechanisms for this
association are uncertain, and a role for troponin testing in the pr
29 but the factors underlying this
association are uncertain.
30 the clinical importance of this
association is uncertain.
31 However, long-term outcomes after
AVNA are uncertain, especially in light of irreversible pacem
32 rction who do not have hypoxemia at
baseline is uncertain.
33 ain endothelium, the role of LRP1 at the
BBB is uncertain.
34 f CHC per se versus adverse health
behaviors is uncertain.
35 tin alone resulted in cardiovascular
benefit is uncertain.
36 cement, its value in patients receiving
BHVs is uncertain.
37 mical events that lead to its stable
binding are uncertain.
38 lesce, and while the effects on
biodiversity are uncertain, we hypothesize that they could eventually
39 However, the correlation with human
biology is uncertain.
40 concordance between cfDNA and tumor
biopsies is uncertain.
41 or treatment of esophageal variceal
bleeding is uncertain.
42 erventions in areas where hotspot
boundaries are uncertain.
43 We hypothesised that people
can be uncertain about their tastes.
44 nectomy during surgery for esophageal
cancer is uncertain and requires clarification.
45 ival among kidney transplant (KT)
candidates is uncertain.
46 Among patients whose need for intensive
care is uncertain, the relationship of intensive care unit (I
47 implementation on the effectiveness of
care is uncertain.
48 d conservative management for low-risk
cases-
is uncertain.
49 ailure have been observed, but the
causality is uncertain.
50 abundant submucosal glands and goblet
cells are uncertain.
51 ea level (GMSL) rose during the 20th
century is uncertain, with little consensus between various reco
52 4 budget in addition to recent, biogenic
CH4 is uncertain.
53 erate forests will respond to climate
change is uncertain; projections range from severe decline to i
54 ocating polypeptide inserts into the
channel is uncertain, as cryo-electron microscopy structures of
55 provided by community health workers (
CHWs)
is uncertain.
56 hildren who receive treatment with
cisplatin are uncertain.
57 major driver of Northern Hemisphere
climate,
is uncertain.
58 rocognitive and cardiovascular
complications is uncertain.
59 ultimate implications for forest
composition are uncertain.
60 orrelations for superconducting
compositions is uncertain.
61 ther settings and to non-research
conditions is uncertain.
62 linical practice, but long-term
consequences are uncertain.
63 and, though the magnitude of such
conversion is uncertain because of the coarse resolution of satelli
64 global terrestrial response to this
cooling is uncertain.
65 igenesis, but the basis for this
cooperation is uncertain.
66 Many corneal specialists
currently are uncertain about the risk benefit associated with the
67 ion of PCP to tubulogenesis and
cystogenesis is uncertain, and two major questions remain unanswered.
68 Although the basis of early
death is uncertain, several organ systems manifest changes in
69 mild cognitive impairment (MCI), or
dementia are uncertain.
70 ontributes to cognitive decline and
dementia is uncertain.
71 mild cognitive impairment (MCI), or
dementia is uncertain.
72 til pandemic vaccine is ready to be
deployed is uncertain.
73 ough the duration of microbialite
deposition is uncertain, it is likely that they formed rapidly (per
74 its target, leading to platelet
destruction,
is uncertain, in part because of the difficulties of wor
75 the rodent model to human brain
development is uncertain.
76 ly still during scanning and whose
diagnosis is uncertain.
77 ildren and animals, but its role in
diarrhea is uncertain.
78 stent versus the underlying cardiac
disease is uncertain, as prior studies lack a control surgical p
79 en intestinal pathogens in diarrheal
disease is uncertain.
80 yocardial infarction and multivessel
disease is uncertain.
81 he outpatient management of chronic
diseases is uncertain.
82 increases the incidence of mental
disorders is uncertain, considerable evidence suggests low rates o
83 ared with other neurodevelopmental
disorders is uncertain.
84 Thus, the net effect on
diversification is uncertain.
85 s in plasma as virion-associated or free
DNA is uncertain.
86 let therapy, including aspirin (ASA)
dosing,
is uncertain.
87 ut incidence and the potential for
dysplasia are uncertain, and the clinical relevance unclear.
88 he variability and durability of this
effect are uncertain.
89 sordered proteins, the extent of this
effect is uncertain.
90 tocyte effect, but the extent of this
effect is uncertain.
91 nfections in MSM, but its cost-
effectiveness is uncertain.
92 cromial shoulder pain, but its
effectiveness is uncertain.
93 atment is expensive and TasP's
effectiveness is uncertain.
94 s and late at night, but their
effectiveness is uncertain where vectors bite outdoors and earlier in
95 wever, their respective and combined
effects are uncertain.
96 loads are available, but symptomatic
effects are uncertain.
97 t fully elucidated and the long-term
effects are uncertain.
98 es into the environment, where their
effects are uncertain.
99 vates behavior change or has adverse
effects is uncertain.
100 ply induces long-lasting symptomatic
effects is uncertain.
101 h current models can represent these
effects is uncertain.
102 ch may counter or exacerbate direct
effects,
is uncertain.
103 ic knee osteoarthritis (OA) but its
efficacy is uncertain.
104 rst episode of unprovoked pulmonary
embolism is uncertain.
105 underlying shear stress-regulation of
EndMT are uncertain.
106 Optimal treatment for HHT-related
epistaxis is uncertain.
107 ming and recurrence intervals of such
events are uncertain.
108 nature, location, and timing of these
events are uncertain.
109 e patient is transferred) and adverse
events is uncertain.
110 Whether it prevents cardiovascular
events is uncertain.
111 he development of cardiovascular (CV)
events is uncertain.
112 rs, but the functional impact of such
events is uncertain.
113 The prognosis of these
events is uncertain.
114 ever, the clinical relevance of these
events is uncertain.
115 troke and peripheral embolic vascular
events is uncertain.
116 Yet, the
evidence is uncertain regarding the role of iron in the developme
117 is and pulmonary embolism), but the
evidence is uncertain.
118 or both processes to work in concert
existed is uncertain.
119 The cause of ice
expansion is uncertain, but most likely it is related to increased
120 rning rate should increase when
expectations are uncertain (uncertainty), outcomes are surprising (su
121 socioeconomic consequences of lead
exposure are uncertain.
122 odalities and function of regenerated
fibers is uncertain.
123 he remaining case with negative aCGH
finding was uncertain.
124 disease, generalizability of these
findings is uncertain as well as the management of found thyrolip
125 Eddy covariance nighttime
fluxes are uncertain due to potential measurement biases.
126 patients with fibromuscular dysplasia (
FMD)
is uncertain.
127 t when they receive cues that access to
food is uncertain.
128 he response of catotelm C to climate
forcing is uncertain, because prior experiments have focused on
129 failure (HF) with reduced ejection
fraction is uncertain.
130 on via fragment crystallizable (Fc)
gammaRIIA is uncertain.
131 d the effectiveness of testing in this
group is uncertain.
132 Future population
growth is uncertain and matters for climate policy: higher grow
133 process compared with recommended
guidelines are uncertain.
134 wever, the significance of mitochondrial
H2S is uncertain, in part due to the difficulty of assessing
135 However, it
has been uncertain whether the observed amnesia in the early
136 lities of uncultured ARMAN-like archaea
have been uncertain.
137 function and pathobiological importance
have been uncertain.
138 medical relevance of this polymorphism
have been uncertain.
139 in the US population's vitamin D status
have been uncertain because of nonstandardized serum 25-hydro
140 tion (LT) for hepatocellular carcinoma (
HCC)
is uncertain.
141 hanisms underlying the effectiveness of
HIIT are uncertain.
142 ibutes to normal development and
homeostasis is uncertain.
143 titis virus infection in glucose
homeostasis is uncertain.
144 f pirfenidone on death after
hospitalization is uncertain.
145 of CRAND as an electron source has,
however,
been uncertain, because measurements have shown that the
146 etween the HDL-C level and asymptomatic
ICAS is uncertain.
147 interventions in intensive care units (
ICUs)
is uncertain.
148 uman bocavirus (HBoV) in respiratory
illness is uncertain.
149 the magnitude of the associated
improvement is uncertain.
150 kely dynamics following an initial
incursion are uncertain, especially the risk of continued spread,
151 arly low-dose CT in all eligible
individuals is uncertain.
152 ictions beyond boreal spring will
inevitably be uncertain if this change is neglected.
153 troduced into the diet of breast-fed
infants is uncertain.
154 enous Gal-1 during acute parasite
infections is uncertain.
155 le of infection as a cause of the
infiltrate is uncertain.
156 the neural implications of this
inheritance are uncertain.
157 linical effectiveness of these
interventions is uncertain.
158 alone in patients with substantial
ischemia is uncertain.
159 It is uncertain how this variability will affect future nvP
160 It is uncertain if outcomes at these hospitals were compara
161 It is uncertain if this is an attainable goal.
162 It is uncertain whether a diagnostic strategy supplemented
163 It is uncertain whether coeliac node metastasis precludes l
164 It is uncertain whether pediatric celiac disease is distinc
165 It is uncertain whether risk of cerebral palsy in offspring
166 It is uncertain whether the duration of red-cell storage af
167 It is uncertain whether the intake of low-dose aspirin duri
168 It is uncertain whether this association is attributable to
169 It is uncertain whether this finding reflects an independen
170 It is uncertain whether vitamin B-12 supplementation can im
171 range of mechanical stimuli, however, and
it is uncertain how differences in tension between the inne
172 us from childhood to early adulthood, and
it is uncertain whether vitamin D predicts peak bone mass i
173 information is only semireliable because
it is uncertain, limited, or confusing in important ways.
174 nd corneal epithelial cells in vitro, but
it is uncertain if MSC can assume corneal epithelial cells
175 ferase (ALT) predicts type 2 diabetes but
it is uncertain whether it also predicts gestational diabet
176 is associated with diabetes mellitus, but
it is uncertain whether it improves cardiovascular disease
177 ad by evolving mutational robustness, but
it is uncertain whether small populations can evolve a redu
178 tients undergoing noncardiac surgery, but
it is uncertain whether that risk is generalizable to patie
179 eased in subclinical hyperthyroidism, but
it is uncertain whether variations in thyroid function with
180 in alpha-, beta-, and gammabaculoviruses,
it is uncertain if this trafficking function is conserved.
181 uterostomes (echinoderms, hemichordates),
it is uncertain whether the ancestral cephalochordates (i.e
182 However,
it is uncertain if and how they influence rhizosphere micro
183 However,
it is uncertain whether management action prompted by a cha
184 However,
it is uncertain whether this relationship extends to LDL-C
185 However,
it is uncertain which patient groups benefit the most from
186 ent evidence is limited and insufficient;
it is uncertain whether treating SWHSI with antiseptics or
187 Therefore
it is uncertain whether sRNAs can enter the nucleoid to tar
188 romboembolism require extended treatment,
it is uncertain whether it is better to use full- or lower-
189 brain abnormalities in their infants, yet
it is uncertain when during pregnancy the human conceptus i
190 ey neuroprotective function of these
kinases is uncertain.
191 production of nuclear power (in g CO2e/
kWh)
are uncertain due partly to a paucity of data on emissio
192 consumption and emission factors, the
latter being uncertain because of very few actual measurements
193 nts, yet how these variants confer
liability is uncertain.
194 oor cognitive function in mid- to later-
life is uncertain.
195 ne, although the basis for this
localization is uncertain.
196 rigin of elements heavier than iron has
long been uncertain.
197 terone and estradiol that initiate bone
loss are uncertain.
198 evance of the chicken as an ecological
model is uncertain.
199 The significance of these
observations is uncertain, but the predominantly calcific morphology
200 als regulate myelination by
oligodendrocytes is uncertain.
201 ppendicitis) where the best treatment
option was uncertain and asked them to: (1) judge the risks (pr
202 any scientists do not know where to begin
or are uncertain that their advocacy efforts will have an i
203 13 out of 51 patients for which the
outcome was uncertain based on current tests.
204 y on vaccine effectiveness (VE) and
outcomes is uncertain.
205 the wound microbiology on clinical
outcomes is uncertain.
206 nts, but the impact of DGF on graft
outcomes is uncertain.
207 maging can impact long-term patient
outcomes is uncertain.
208 inuria, yet the impact on long-term
outcomes is uncertain in chronic kidney disease (CKD).
209 treatment affected patient-reported
outcomes was uncertain; those results from the trial are reported
210 le in adult sinoatrial node (SAN)
pacemaking is uncertain.
211 conditions, but its effects on low back
pain are uncertain.
212 bowel disease, but its role in
pathogenesis is uncertain.
213 eeding complications during transfemoral
PCI is uncertain.
214 n of pancreatic ductal adenocarcinoma (
PDAC)
is uncertain.
215 and herd protection in unvaccinated
persons is uncertain.
216 ealth consequences of exposure to
pesticides are uncertain and subject to much debate.
217 entity of these early anoxygenic
phototrophs is uncertain, including whether or not they remain extan
218 probability of survival for which
physicians are uncertain of whether or not to perform a surgery.
219 f structural detail, but taxonomic
placement is uncertain because plumage is rarely associated with i
220 cture and function in the general
population is uncertain.
221 to study drugs or low risk in the
population is uncertain.
222 care will be an answer for these
populations is uncertain.
223 Calpha atoms of the residues whose
positions are uncertain from the distribution, and accepts or reje
224 eeding 2 degrees C, but the global
potential is uncertain.
225 se on wheat yield in regions of high
poverty are uncertain.
226 ncrease with climate change, but
predictions are uncertain because humans can modulate or even overri
227 ctive approach to management of this
problem is uncertain.
228 n or, in fact, a part of the disease
process is uncertain.
229 of the Y chromosome (MSY) in these
processes are uncertain.
230 lar mechanisms orchestrating these
processes are uncertain.
231 beyond a common vascular risk factor
profile is uncertain.
232 nefits of pay-for-performance (P4P)
programs are uncertain.
233 effect of hospitalization-based
prophylaxis are uncertain.
234 The patient's survival
rate is uncertain due to the limitations of cancer diagnosis
235 The magnitude of increase in breakdown
rates is uncertain, given differences in litter quality and mi
236 ality after stroke than men, but the
reasons are uncertain.
237 ged electroencephalographic (EEG)
recordings are uncertain.
238 are independent or pathobiologically
related is uncertain.
239 ng inflammation; therefore, causal
relations are uncertain.
240 fects were small, and the clinical
relevance is uncertain, although polygenic score analyses may prov
241 for herd protection and serotype
replacement is uncertain.
242 One reason is that
researchers are uncertain about how sharing their work will affect t
243 oblem, especially when the timing of
rewards is uncertain.
244 but the mechanisms of this differential
risk are uncertain.
245 The reasons for apoE isoform-selective
risk are uncertain; however, both the amounts and structure o
246 lin analogs and increased breast cancer
risk is uncertain, particularly with the short follow-up in p
247 of triggers for violent acts to these
risks is uncertain.
248 in poorly understood and their climatic
role is uncertain.
249 a, although whether they play a primary
role is uncertain.
250 ery is valuable where feasibility and
safety are uncertain.
251 cellular Ca(2+) on repolarization in the
SAN is uncertain.
252 ry detection mechanism of this compass
sense is uncertain but appears to involve the quantum spin dyn
253 significance of albuminuria in this
setting is uncertain and should not necessarily rule out EVR-bas
254 , and the generalizability to other
settings is uncertain.
255 value in patients without daytime
sleepiness is uncertain.
256 oach we take here relies on limited data,
so is uncertain, but it provides cheap, safe and direct evi
257 when the time of occurrence of the test
song was uncertain.
258 ess and effect on total health care
spending are uncertain.
259 ment-elevation myocardial infarction (
STEMI)
is uncertain.
260 When the right decision
strategy is uncertain, as in most natural settings, feedback beco
261 ignettes wherein the best treatment
strategy was uncertain.
262 heir contribution to CHD risk
stratification is uncertain.
263 of survivors' cognitive changes after
stroke is uncertain.
264 of recurrent stroke after cryptogenic
stroke is uncertain.
265 medical therapy alone for cryptogenic
stroke is uncertain.
266 n 6 hours after the onset of ischemic
stroke is uncertain.
267 benefits and safety of such
supplementation are uncertain.
268 l membrane oxygenation after cardiac
surgery is uncertain.
269 predicting adverse events following
surgery is uncertain in the current literature.
270 vance to improving progression-free
survival is uncertain and will require further follow-up.
271 predictable, but not when the next
syllable was uncertain.
272 l in patients with antiphospholipid
syndrome is uncertain.
273 ity associated with chronic fatigue
syndrome is uncertain.
274 ays a causal role in the pathogenesis of
T2D is uncertain.
275 nal role of MLIs during specific motor
tasks is uncertain.
276 cholesterol (HDL-C) and triglycerides (
TGs)
is uncertain.
277 linical decisions to initiate statin
therapy are uncertain.
278 renal cancer in the era of targeted
therapy is uncertain.
279 her alone or in combination with
thiopurines is uncertain.
280 r injury but the exposures that lead to
this are uncertain.
281 The severity of this
threat is uncertain because the consequences of resistance for
282 ation as low risk, but the optimal
threshold is uncertain.
283 pothermia, length of its use, and its
timing are uncertain.
284 the drivers of intratumoral immune
tolerance are uncertain.
285 The covalent structure of the Ts3
toxin is uncertain, and the structure of the folded protein mo
286 l length of RBC storage prior to
transfusion are uncertain.
287 st 24 hours, but the optimal duration of
TTM is uncertain.
288 However, its contributions to
tumorigenesis are uncertain and have been disputed.
289 t optimal strategies for out-of-hospital
use are uncertain.
290 idely prescribed, associations with
violence are uncertain.
291 domain, can support membrane fusion in
vivo is uncertain, as is the precise role of Munc18-2 during
292 nd in primary and secondary plant cell
walls is uncertain, but their presence enables further study o
293 We are uncertain about effects on long-term economic produc
294 We are uncertain as to the reason for this and do not know
295 ing plasma tariquidar concentrations, but
we are uncertain whether maximal uptake was achieved.
296 or secondary effect of abnormal body
weight is uncertain.
297 microvascular injury, the mechanism of
which is uncertain, but which may be due to cyclic interruptio
298 d on two cognitive tests, the cause of
which is uncertain.
299 e recommendations for a specific patient
who is uncertain whether to proceed to screening.
300 th (PTB) risk, but critical exposure
windows are uncertain.